Skip to content
The Inflation Reduction Act was meant to be a step forward in improving the affordability and access to innovative medical treatments, but several provisions […]
Podcast: The impact of the Inflation Reduction Act and EU pharma package on innovation Read More »
Discovered only about a decade ago, CRISPR Cas-9 enables rapid development of exciting new treatments—and more breakthroughs are on the way, today’s new episode of
I am BIO Podcast: CRISPR revolution just starting Read More »
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D for HIV/AIDS, and the
I am BIO Podcast: Accelerated Approval, accelerating hope Read More »
In recent years, Artificial Intelligence (AI) has boomed in healthcare. AI is helping scientists obtain relevant data, accurately predict diseases at early stages, and
I am BIO Podcast: How AI and biotech can ‘run evolution at hyperspeed’ Read More »
Discussing women’s health seems to make some people uncomfortable, but this vital concern for half the world’s population needs more discussion, and investment, a
I am BIO Podcast: We need to talk about, and invest in, women’s health Read More »
Biotechnology can provide solutions to the plastic pollution that is destroying our seas and streams—and opera can help too. Biotech solutions include plant-based bioplastics
I am BIO Podcast: Fighting pollution with microbes, bioplastics—and opera Read More »
The most recent illustration of the strength of patient advocacy is the FDA’s approval of new ALS medicine, which was developed with $2 million
Podcast tells of patient advocates improving drug development Read More »
The recent drop in the stock market is creating a difficult situation for biotechnology, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath
I am BIO Podcast explores investment climate for biotech Read More »
The convoluted, confusing, and opaque system for pricing drugs is distorting the market—and limiting access to drugs for the sickest patients. This is the
I am BIO Podcast: Dysfunctional drug market means sickest pay more Read More »
In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the
I am BIO Podcast: Hope for Alzheimer’s Read More »
